Live Breaking News & Updates on Nuvectis pharma company profile
Stay updated with breaking news from Nuvectis pharma company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insider Buying: Nuvectis Pharma, Inc. (NASDAQ:NVCT) Major Shareholder Acquires $11,936.80 in Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Free Report) major shareholder Marlio Charles Mosseri acquired 860 shares of Nuvectis Pharma stock in a transaction that occurred on Monday, July 31st. The shares were bought at an average price of $13.88 per share, for a total transaction of $11,936.80. Following the transaction, the insider now owns 2,595,000 […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Free Report) major shareholder Marlio Charles Mosseri bought 5,394 shares of the business’s stock in a transaction that occurred on Thursday, July 20th. The stock was acquired at an average cost of $14.40 per share, with a total value of $77,673.60. Following the completion of the acquisition, the insider […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT) Major Shareholder Purchases $135,920.12 in Stock theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Baldwin Brothers LLC MA increased its position in shares of Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) by 7.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 143,800 shares of the company’s stock after acquiring an additional 10,500 shares […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Free Report) major shareholder Marlio Charles Mosseri purchased 16,760 shares of the company’s stock in a transaction that occurred on Monday, June 26th. The shares were purchased at an average price of $16.46 per share, for a total transaction of $275,869.60. Following the completion of the transaction, the insider now […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Rating) CEO Ron Bentsur purchased 750 shares of the firm’s stock in a transaction that occurred on Monday, June 26th. The stock was bought at an average cost of $16.50 per share, for a total transaction of $12,375.00. Following the completion of the purchase, the chief executive officer now […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Rating) – HC Wainwright boosted their Q2 2023 earnings per share (EPS) estimates for Nuvectis Pharma in a report issued on Wednesday, May 10th. HC Wainwright analyst J. Pantginis now forecasts that the company will post earnings of ($0.41) per share for the quarter, up from their prior estimate […]
Nuvectis Pharma, Inc. (NASDAQ:NVCT – Get Rating) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 186,300 shares, a growth of 24.2% from the March 31st total of 150,000 shares. Based on an average daily volume of 56,900 shares, the […]
Should You Buy or Sell Nuvectis Pharma Stock? Get The Latest NVCT Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.